March 21, 2010 - Senator Chuck Grassley has asked PBMs to describe their efforts to enhance the transparency of financial benefits they receive from drug makers. To learn more please see: http://grassley.senate.gov/news/Article.cfm?customel_dataPageID_1502=25752
February 9, 2010 - The Federal Trade Commission is investigating allegations of improper business practices by a firm that provides prescription drug services for health insurance companies that cover most federal employees. FTC probing CVS Caremark's Prescription Drug Practices — Washington Post
March 8, 2010 - A bill that would require greater PBM transparency within the Federal Employees Health Benefits Program received some criticism during a recent hearing from the Office of Personnel Management, which says it just directed health plans to improve PBM contracting practices in order to control the program's swelling drug costs....Visit http://www.aishealth.com/GNOW/030810.html#gnowthree for more information.
|
